Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto M Lemoli

Showing results (11-20 of 106) with videos related to

Pageof 11
Sort By:
Cancers|March 10, 2022
Measurable Residual Disease in High-Risk Acute Myeloid LeukemiaThomas Cluzeau, Roberto M Lemoli, James McCloskey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 2003
Dendritic cell differentiationAntonio Curti, Elisa Ferri, Simona Pandolfi, et al.
Expert Review of Anticancer Therapy|July 20, 2016
Exploiting tumor vulnerabilities: NAD(+)-depleting agents combined with anti-tumor drugs as innovative strategy to treat hematological malignanciesMichele Cea, Debora Soncini, Marco Gobbi, et al.
Haematologica|November 5, 2002
The therapeutic role of dendritic cells in cancer immunotherapyRoberto M Lemoli, Antonio Curti, Miriam Fogli, et al.
Blood|November 22, 2008
The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematologyAntonio Curti, Sara Trabanelli, Valentina Salvestrini, et al.
Blood|July 13, 2012
The sixth sense: hematopoietic stem cells detect danger through purinergic signalingLara Rossi, Valentina Salvestrini, Davide Ferrari, et al.
Journal of Immunology Research|March 28, 2015
PGE2-induced IDO1 inhibits the capacity of fully mature DCs to elicit an in vitro antileukemic immune responseSara Trabanelli, Mariangela Lecciso, Valentina Salvestrini, et al.
Stem Cells and Development|December 25, 2012
Extracellular purines promote the differentiation of human bone marrow-derived mesenchymal stem cells to the osteogenic and adipogenic lineagesMarilena Ciciarello, Roberta Zini, Lara Rossi, et al.
Oncotarget|December 2, 2016
The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signalingDorian Forte, Valentina Salvestrini, Giulia Corradi, et al.
Frontiers in Oncology|March 6, 2024
Literature review and expert opinion on the treatment of high-risk acute myeloid leukemia in patients who are eligible for intensive chemotherapyRaffaele Palmieri, Atto Billio, Felicetto Ferrara, et al.
Pageof 11

Showing results (11-20 of 106) with videos related to

Sort By:
Pageof 11
Cancers|March 10, 2022
Measurable Residual Disease in High-Risk Acute Myeloid LeukemiaThomas Cluzeau, Roberto M Lemoli, James McCloskey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 2003
Dendritic cell differentiationAntonio Curti, Elisa Ferri, Simona Pandolfi, et al.
Expert Review of Anticancer Therapy|July 20, 2016
Exploiting tumor vulnerabilities: NAD(+)-depleting agents combined with anti-tumor drugs as innovative strategy to treat hematological malignanciesMichele Cea, Debora Soncini, Marco Gobbi, et al.
Haematologica|November 5, 2002
The therapeutic role of dendritic cells in cancer immunotherapyRoberto M Lemoli, Antonio Curti, Miriam Fogli, et al.
Blood|November 22, 2008
The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematologyAntonio Curti, Sara Trabanelli, Valentina Salvestrini, et al.
Blood|July 13, 2012
The sixth sense: hematopoietic stem cells detect danger through purinergic signalingLara Rossi, Valentina Salvestrini, Davide Ferrari, et al.
Journal of Immunology Research|March 28, 2015
PGE2-induced IDO1 inhibits the capacity of fully mature DCs to elicit an in vitro antileukemic immune responseSara Trabanelli, Mariangela Lecciso, Valentina Salvestrini, et al.
Stem Cells and Development|December 25, 2012
Extracellular purines promote the differentiation of human bone marrow-derived mesenchymal stem cells to the osteogenic and adipogenic lineagesMarilena Ciciarello, Roberta Zini, Lara Rossi, et al.
Oncotarget|December 2, 2016
The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signalingDorian Forte, Valentina Salvestrini, Giulia Corradi, et al.
Frontiers in Oncology|March 6, 2024
Literature review and expert opinion on the treatment of high-risk acute myeloid leukemia in patients who are eligible for intensive chemotherapyRaffaele Palmieri, Atto Billio, Felicetto Ferrara, et al.
Pageof 11